In this post, we interview Rebecca Fitzgerald, chief investigator for the BEST3 trial. Her work at the MRC Cancer Unit focuses on the early detection… Read More »Best of BEST3: An interview with Rebecca Fitzgerald, Chief Investigator
In this post, we interview Irene Debiram-Beecham, clinical coordinator for the BEST3 trial. Irene is a Senior Research Sister in Professor Rebecca’s Fitzgerald’s group and… Read More »Best of BEST3: An interview with Irene Debiram-Beecham, clinical coordinator
A friend of mine in her late 40s has just been diagnosed with breast cancer. Fortunately, she spotted it early and it sounds as if… Read More »Breast screening for women in their 40s – what are we waiting for?
In this post Rose Brade, International Policy Advisor at Cancer Research UK provides her personal experiences with vaccine hesitancy and the implications for cervical cancer… Read More »Vaccine hesitancy and disease prevention – It’s not just coronavirus which stands to lose
In this blog, we interview Beth Muldrew, Clinical Project Manager for the BEST3 trial. Beth successfully managed the project from start-up to conclusion, working across… Read More »Best of BEST3: a Q&A with Beth Muldrew, Clinical Project Manager
The results of the BEST3 trial have just been published and the findings have exceeded even our most optimistic expectations. This trial showed that the… Read More »Best of BEST3: A (not so) hard pill to swallow- an overview of BEST3 & the Cytosponge
Amanda Dibden is a statistician at Queen Mary University of London. Here she highlights the main results from her recently published worldwide review and meta-analysis… Read More »Is mammography screening still worthwhile? The results of a review provide some answers…
Our “Five Minutes With” series seeks to discover what are the habits, inspirations and obstacles that have shaped the careers of leading cancer researchers and… Read More »Five minutes with: Professor Patti Gravitt
In this blog Dr Mieke Van Hemelrijck, Reader (Associate Professor) in Cancer Epidemiology in the School of Cancer & Pharmaceutical Sciences at King’s College London… Read More »Cancer outcomes during COVID: building on existing datasets & collaborations
David McCoy is Professor of Global Public Health at Queen Mary University London, where he’s involved in delivering a multi-disciplinary and critical undergraduate and postgraduate… Read More »Professor David McCoy’s COVID manifesto
